Lorazepam

is prescribed to treat:

• Anxiety disorders and short-term anxiety relief • Various related conditions in the mental health category • Associated symptoms and complications

It is an important medication that helps manage these conditions effectively.

Lorazepam (Ativan) is a benzodiazepine used for anxiety, insomnia, status epilepticus, alcohol withdrawal, procedural sedation, and as an antiemetic in chemotherapy. Its pharmacokinetics make it the benzodiazepine of choice in several specific situations where others are less suitable.

Mechanism of Action

Lorazepam binds an allosteric site on the GABA-A receptor, increasing the frequency with which the chloride channel opens in response to GABA. Potentiating the principal inhibitory neurotransmitter produces anxiolysis, sedation, muscle relaxation, anterograde amnesia, and anticonvulsant activity.

Because it enhances GABA rather than acting directly on the channel, it cannot open it without GABA present — which is why benzodiazepines alone are comparatively difficult to overdose on fatally, and why combining them with opioids or alcohol removes that safety margin entirely.

Two pharmacokinetic features define lorazepam's place. It is conjugated directly by glucuronidation without requiring oxidative CYP metabolism, and it has no active metabolites. Most other benzodiazepines — diazepam and alprazolam among them — depend on hepatic oxidation and, in diazepam's case, generate long-lived active metabolites that accumulate.

That difference makes lorazepam the preferred benzodiazepine in liver disease and in older adults, where oxidative capacity declines and accumulation causes prolonged sedation and confusion. Glucuronidation is comparatively preserved in both groups.

Its intermediate half-life produces less inter-dose rebound than alprazolam while remaining shorter-acting than clonazepam. It is also reliably absorbed intramuscularly, unlike diazepam, which matters when intravenous access is unavailable in a seizing patient.

Clinical Use

In status epilepticus, intravenous lorazepam is a first-line agent, with a longer duration of anticonvulsant effect than diazepam because it redistributes out of the brain more slowly.

In alcohol withdrawal it is widely used, particularly in patients with liver disease where its metabolism is an advantage, and symptom-triggered dosing produces better outcomes than fixed schedules.

For anxiety, benzodiazepines have legitimate short-term uses — acute crisis, bridging the first weeks of an SSRI, procedural anxiety — but they are not first-line for chronic anxiety disorders. SSRIs and SNRIs such as sertraline and escitalopram, together with cognitive behavioural therapy, are, and CBT produces durable benefit that outlasts treatment in a way no medication does.

Tolerance develops to the anxiolytic effect with sustained use, so long-term benzodiazepine treatment often means taking a drug that no longer treats the condition while continuing to produce dependence. Where ongoing treatment is genuinely needed, the plan should be explicit from the outset. The St. Pete mental health guide covers alternatives, and our psychiatric team manages anxiety treatment.

Dependence and Withdrawal

Physical dependence develops with regular use over weeks and is a predictable pharmacologic consequence rather than a sign of addiction. It means abrupt cessation causes withdrawal, and benzodiazepine withdrawal is genuinely dangerous — unlike opioid withdrawal it can produce seizures and delirium and can be fatal.

Tapering must be gradual, over months rather than weeks after prolonged use. A patient taking lorazepam daily for years cannot simply be told to stop, and being told so is a common reason people obtain it elsewhere.

The FDA added a boxed warning in 2020 covering abuse, misuse, addiction, dependence, and withdrawal across the class, alongside the existing warning about combining benzodiazepines with opioids — a combination that substantially increases respiratory depression and overdose death. The FDA benzodiazepine safety communication sets this out.

Monitoring and Follow-Up

No laboratory monitoring is required. What must be monitored is the pattern of use: dose, frequency, whether it is escalating, whether early refills are requested, and whether the original indication still applies.

Prescription drug monitoring program checks are appropriate given the controlled-substance status. Falls, cognitive complaints, and daytime sedation should be assessed at each review, particularly in older patients.

Anterograde amnesia is a genuine effect and is exploited deliberately in procedural sedation, but it also means patients may not recall conversations or instructions given while taking it — worth knowing when important information is being conveyed.

The key review question is whether there is a plan. A patient with a documented taper plan and concurrent SSRI or therapy is in a different position from one refilled indefinitely with neither. The MedlinePlus lorazepam entry covers prescribing detail.

Special Populations

In older adults, benzodiazepines appear on lists of medications to avoid. They increase falls, fractures, motor vehicle accidents, and confusion, and are associated with cognitive impairment. Lorazepam is the least problematic of the class in this group because of its metabolism, which makes it the usual choice when one is genuinely required — but that is a relative rather than an absolute reassurance. The benzodiazepine deprescribing article covers tapering safely, which is often more valuable than any new prescription.

In hepatic impairment, lorazepam is preferred over oxidatively metabolised benzodiazepines. In pregnancy they are generally avoided, with neonatal withdrawal a concern with third-trimester use. They pass into breast milk. Lorazepam is contraindicated in narrow-angle glaucoma and warrants caution in significant respiratory disease and sleep apnea. A history of substance use disorder markedly raises the risk of problematic use.

Driving deserves an explicit word. Benzodiazepines impair reaction time and judgement measurably, the effect persists longer than the subjective sense of sedation, and it is additive with alcohol. Patients should not drive until they know how a dose affects them, and should not drive at all after a dose taken for acute anxiety.

When to Contact Your Doctor

Seek emergency care for extreme sleepiness, confusion, slowed or difficult breathing, or unresponsiveness — particularly if opioids, alcohol, or other sedatives are also involved.

Never stop lorazepam abruptly after regular use. Report withdrawal symptoms during a taper — anxiety, insomnia, tremor, sweating, sensory disturbance — so it can be slowed, and seek urgent care for seizure or severe confusion.

Report falls, memory problems, or daytime sedation. If the dose no longer lasts, or you are taking more than prescribed, raise it directly; that is a treatable situation rather than a reason for a difficult conversation.

To discuss anxiety treatment, plan a safe taper, or review whether a benzodiazepine is still appropriate, contact us or schedule a visit.